SMRI vs. PRXV

Last updated Jun 24, 2026

SMRI (Bushido Capital US Equity ETF) and PRXV (Praxis Impact Large Cap Value ETF) are both Large Cap Value Equities funds. Both are actively managed. At a 0.44 correlation, their price movements are largely independent. SMRI charges 0.71%/yr vs 0.36%/yr for PRXV.

Performance

SMRI vs. PRXV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bushido Capital US Equity ETF (SMRI) and Praxis Impact Large Cap Value ETF (PRXV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

SMRI

• 1D: -0.89%
• 1M: 1.02%
• YTD: 12.23%
• 6M: 10.92%
• 1Y: 26.23%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PRXV

• 1D: -0.29%
• 1M: 3.50%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SMRI vs. PRXV - Yearly Performance Comparison

	2026 (YTD)
SMRI Bushido Capital US Equity ETF	7.92%
PRXV Praxis Impact Large Cap Value ETF	6.54%

Correlation

The correlation between SMRI and PRXV is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Apr 20, 2026	0.44

Return for Risk

SMRI vs. PRXV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMRI

SMRI Risk / Return Rank: 63
SMRI Sharpe Ratio Rank: 56
SMRI Sortino Ratio Rank: 57
SMRI Omega Ratio Rank: 54
SMRI Calmar Ratio Rank: 81
SMRI Martin Ratio Rank: 66

PRXV

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMRI vs. PRXV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bushido Capital US Equity ETF (SMRI) and Praxis Impact Large Cap Value ETF (PRXV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SMRI	PRXV	Difference
Sharpe ratio: Return per unit of total volatility	1.73	—	—
Sortino ratio: Return per unit of downside risk	2.47	—	—
Omega ratio: Gain probability vs. loss probability	1.31	—	—
Calmar ratio: Return relative to maximum drawdown	3.87	—	—
Martin ratio: Return relative to average drawdown	11.00	—	—

Drawdowns

SMRI vs. PRXV - Drawdown Comparison

The maximum SMRI drawdown since its inception was -18.45%, which is greater than PRXV's maximum drawdown of -1.41%. Use the drawdown chart below to compare losses from any high point for SMRI and PRXV.

Drawdown Indicators

	SMRI	PRXV	Difference
Max Drawdown Largest peak-to-trough decline	-18.45%	-1.41%	-17.04%
Max Drawdown (1Y) Largest decline over 1 year	-6.80%	—	—
Current Drawdown Current decline from peak	-6.47%	-0.29%	-6.18%
Average Drawdown Average peak-to-trough decline	-2.74%	-0.41%	-2.33%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.39%	—	—

Volatility

Volatility by Period

	SMRI	PRXV	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.26%	—	—
Volatility (6M) Calculated over the trailing 6-month period	11.74%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	15.25%	10.64%	+4.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.95%	10.64%	+5.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.95%	10.64%	+5.31%

SMRI vs. PRXV - Expense Ratio Comparison

SMRI has a 0.71% expense ratio, which is higher than PRXV's 0.36% expense ratio.

Dividends

SMRI vs. PRXV - Dividend Comparison

SMRI's dividend yield for the trailing twelve months is around 1.00%, while PRXV has not paid dividends to shareholders.

Position	TTM	2025	2024	2023
PRXV Praxis Impact Large Cap Value ETF	0.00%	0.00%	0.00%	0.00%
SMRI Bushido Capital US Equity ETF	1.00%	1.32%	0.98%	0.45%

Frequently Asked Questions

Can I hold both SMRI and PRXV in my portfolio?

SMRI and PRXV have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, SMRI or PRXV?

On fees, PRXV is cheaper at 0.36% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, SMRI or PRXV?

PRXV is cheaper with a 0.36% expense ratio, compared with 0.71% for SMRI.

Which ETF pays a higher dividend yield, SMRI or PRXV?

SMRI has the higher dividend yield at 1.00%, compared with 0.00% for PRXV.

What is the main difference between SMRI and PRXV?

They also come from different issuers: Bushido and Praxis. Their fees differ too: 0.71% for SMRI and 0.36% for PRXV.